Grigoris Chlouverakis

7PUBLICATIONS
68CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cell physiologyEpidemiological methodsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 13, 2026
Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.

Andreas Goette, Marc D Lemoine, Alexander Fierenz

|Jan 15, 2026
Defining obstruction in COPD: do fixed ratio and lower limit of normal criteria reflect different clinical characteristics? findings from a Greek cross-sectional study (EMENO).

Μaria Gangadi, Natasa Kalpourtzi, Μagda Gavana

|Sep 02, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.

Renate B Schnabel, Juan Benezet-Mazuecos, Nina Becher

|Aug 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.

Hans Christoph Diener, Nina Becher, Susanne Sehner

|Apr 09, 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.

Gregory Y H Lip, Julius Nikorowitsch, Susanne Sehner

|Mar 31, 2023
Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO.

Aliki I Venetsanopoulou, Natasa Kalpourtzi, Yannis Alamanos

Pageof 2

Frequent Collaborators

4 joint publications

Tobias Toennis

4 joint publications

A John Camm

4 joint publications

Antonia Zapf

4 joint publications

Paulus Kirchhof